• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性弥漫性纤维化肺泡炎的不同治疗方法及影响治疗反应的因素。

Different therapies and factors influencing response to therapy in idiopathic diffuse fibrosing alveolitis.

作者信息

Costabel U, Matthys H

出版信息

Respiration. 1981;42(3):141-9. doi: 10.1159/000194420.

DOI:10.1159/000194420
PMID:7313338
Abstract

The success of 3 different treatment regimens was compared in 15 patients with diffuse fibrosing alveolitis. Improvement or deterioration of lung function (vital capacity (VC) and PaO2 changes during exercise) were used as a control of therapy. The combination of prednisolone and azathioprine proved to be most effective: in 4 of 6 patients both VC and PaO2 improved. Combinations with D-penicillamine resulted in a high number of unwanted side effects: in 5 of 13 treated patients it had to be withdrawn. 6 patients were treated with prednisolone alone; only 1 of them improved. Patients with a short duration of symptoms prior to therapy and initially mild impairment of lung function showed a higher degree of improvement during therapy. The consequence for the management of lung fibrosis is to establish diagnosis and treatment as early as possible.

摘要

对15例弥漫性纤维化肺泡炎患者比较了3种不同治疗方案的疗效。肺功能(肺活量(VC)和运动期间的动脉血氧分压(PaO2)变化)的改善或恶化被用作治疗的对照指标。泼尼松龙和硫唑嘌呤联合使用被证明是最有效的:6例患者中有4例的VC和PaO2均有所改善。与青霉胺联合使用产生了大量不良副作用:13例接受治疗的患者中有5例不得不停药。6例患者仅接受泼尼松龙治疗;其中只有1例有所改善。治疗前症状持续时间短且最初肺功能轻度受损的患者在治疗期间改善程度更高。肺纤维化治疗的结果是尽早确立诊断并进行治疗。

相似文献

1
Different therapies and factors influencing response to therapy in idiopathic diffuse fibrosing alveolitis.特发性弥漫性纤维化肺泡炎的不同治疗方法及影响治疗反应的因素。
Respiration. 1981;42(3):141-9. doi: 10.1159/000194420.
2
[Treatment of idiopathic fibrosing alveolitis. Therapeutic experiences with azathioprine-prednisolone and D-penicillamine-prednisolone combination therapy].
Schweiz Med Wochenschr. 1977 Feb 12;107(6):184-7.
3
[Some pharmacological facts for the therapy of idiopathic fibrosing alveolitis (author's transl)].
Prax Pneumol. 1976 Nov;30(11):680-3.
4
[Idiopathic fibrosing alveolitis].
Fortschr Med. 1977 Sep 22;95(25):2157-61.
5
[Treatment of patients with idiopathic fibrosing alveolitis (personal experience and information from the literature)].
Ter Arkh. 1983;55(10):49-52.
6
[The effects of two types of treatment on vital capacity, functional residual capacity and blood gases in idiopathic fibrosing alveolitis (author's transl)].[两种治疗方法对特发性肺纤维化患者肺活量、功能残气量及血气的影响(作者译)]
Prax Klin Pneumol. 1980 Nov;34(11):651-6.
7
[Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)].
Prax Klin Pneumol. 1979 Apr;33 Suppl 1:680-8.
8
[Idiopathic fibrosing alveolitis (IFA)--clinical characteristics, cardiopulmonary functions, and therapeutic methods].[特发性肺纤维化(IFA)——临床特征、心肺功能及治疗方法]
Kokyu To Junkan. 1978 Jan;26(1):29-34.
9
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.比较单独使用泼尼松龙与环磷酰胺及低剂量泼尼松龙联合使用治疗隐源性纤维性肺泡炎的随机对照试验。
Thorax. 1989 Apr;44(4):280-8. doi: 10.1136/thx.44.4.280.
10
Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis.隐源性纤维性肺泡炎。肺生理学和支气管肺泡灌洗与治疗反应及预后的关系。
Am Rev Respir Dis. 1981 Jul;124(1):1-8. doi: 10.1164/arrd.1981.124.1.1.

引用本文的文献

1
Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease.米唑立宾治疗一名患有抗合成酶相关间质性肺病的老年糖尿病患者。
J Rural Med. 2020 Oct;15(4):225-229. doi: 10.2185/jrm.2020-018. Epub 2020 Oct 1.